Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia
Kyle D. Medak, Hesham Shamshoum, Willem T. Peppler, et al.
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 6, pp. E1101-E1111
Closed Access | Times Cited: 15

Showing 15 citing articles:

Therapeutic management of atypical antipsychotic‑related metabolic dysfunctions using GLP‑1 receptor agonists: A systematic review
Octavian Vasiliu
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 38
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain
Ye Yang, Renrong Wu
European Archives of Psychiatry and Clinical Neuroscience (2025)
Closed Access | Times Cited: 1
Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches
Hesham Shamshoum, Kyle D. Medak, David C. Wright
Behavioural Brain Research (2020) Vol. 400, pp. 113049-113049
Closed Access | Times Cited: 15
Fasting or the short‐term consumption of a ketogenic diet protects against antipsychotic‐induced hyperglycaemia in mice
Hesham Shamshoum, Kyle D. Medak, Greg L. McKie, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 11, pp. 2713-2728
Closed Access | Times Cited: 9
GLP-1 agonists: superior for mind and body in antipsychotic-treated patients?
Kateřina Horská, Jana Kučerová, Silje Skrede
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 9, pp. 628-638
Closed Access | Times Cited: 9
Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
Dejuan Li, Qin Yue, Lu Liu, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 8, pp. 1267-1279
Open Access | Times Cited: 11
Ranuncoside’s attenuation of scopolamine-induced memory impairment in mice via Nrf2 and NF-ĸB signaling
Hafiza Sara Salahuddin, Sobia Attaullah, Shahid Ali Shah, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101702-101702
Open Access | Times Cited: 4
Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model
Kateřina Horská, Jan Kučera, Eva Dražanová, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116763-116763
Open Access | Times Cited: 1
Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
Kyle D. Medak, Alyssa J. Weber, Hesham Shamshoum, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Disrupted glucose homeostasis and glucagon and insulin secretion defects in Robo βKO mice
Melissa T. Adams, Bayley J. Waters, Sutichot D. Nimkulrat, et al.
The FASEB Journal (2023) Vol. 37, Iss. 8
Open Access | Times Cited: 2
Olanzapine’s effects on hypothalamic transcriptomics and kinase activity
Sandra Pereira, L Castellani, Chantel Kowalchuk, et al.
Psychoneuroendocrinology (2024) Vol. 163, pp. 106987-106987
Closed Access
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Mushraf Syed, Kiran Chawla, Fayaz SM, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access
Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine
Kyle D. Medak, Stewart Jeromson, A. Bellucci, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108628-108628
Open Access
Fasting and the short‐term consumption of a ketogenic diet are sufficient interventions to protect against OLZ‐induced hyperglycaemia in mice
Joshua M. Budd, Brittany MacIntyre
The Journal of Physiology (2022) Vol. 600, Iss. 15, pp. 3393-3395
Closed Access
Page 1

Scroll to top